Mercaptopyridinecarboxylic acids, synthesis and hypoglycemic activity.
D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003864:Depression, Chemical; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects; D006168:Guinea Pigs; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007672:Kidney Cortex / Q000187:drug effects; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D051379:Mice; D010848:Picolinic Acids / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D013438:Sulfhydryl Compounds / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D010848:Picolinic Acids; D013438:Sulfhydryl Compounds